Here's some fun: cnnfn.cnn.com
And the follow-up:
quote.yahoo.com
Talking Stocks: Battipaglia
Stock strategist at Gruntal & Co. answers
your e-mail questions
February 4, 2000: 1:35 p.m. ET
NEW YORK (CNNfn) - Each Friday at 1 p.m. ET, CNNfn viewers are invited to call in
to the "Talking Stocks" segment and ask the guest expert questions about equities.
Here, Joseph Battipaglia, stock strategist at Gruntal & Co., answers your e-mails.
Name: Gigi, Mass.
Question: What is your opinion long-term? I would like to purchase a "budding"
CMGI (CMGI: Research, Estimates) or other cheaper stock preference in this
communications group.
Battipaglia: Long-term we're very bullish on CMGI. We believe the company has a
very bright future. It's hard to put a value on it; assets are real, the potential is quite
large.
Name: Ali, United Arab Emirates.
Question: I would like to know your opinion about Lucent Technologies (LU:
Research, Estimates).
Battipaglia: We have been given an excellent opportunity to buy the stock again.
We're confident that the management can correct their operations problems, and at
the same time, we're very excited for their fiber optical area, which might spin off
soon. It's a great time to buy some more of this stock at these levels.
Name: Carl, S.C.
Question: Compaq Computer (CPQ: Research, Estimates): What is the reason for
this stock's inability to get off the bottom?
Battipaglia: First of all, the PC business has become commoditized, because of
constant price pressures in market place. You're basically looking at a mature industry
here, which will not give the kind of returns it has given in the past. I would sell
Compaq, as well as Dell.
Name: Rick, Vermont.
Question: Do you feel it makes sense to have holdings in both America Online
(AOL: Research, Estimates) and Time Warner (TWX: Research, Estimates), or should
one concentrate their investment in only one of the companies to be involved in the
merger?
Battipaglia: If you already own both companies, stay with both. If you don't, than
buy AOL at this time.
Name: Rick, Vermont.
Question: Is it better in your estimation to hold a couple of larger profile stocks
such as Oracle (ORCL: Research, Estimates) and General Electric (GE: Research,
Estimates) and add to them in your share investment, or to diversify into some of the
smaller companies such as Genome Therapeutics (GENE: Research, Estimates) that
seem to be making consistent gains?
Battipaglia: Oracle is a business-to-business facilitator on the Internet. We're very
bullish on it and we would buy the stock at this level.
Name: Tom, Fla.
Question: What is your short term stock price projection for K Mart (KM:
Research, Estimates)?
Battipaglia: I would swap out of Kmart and buy Wal-Mart (WMT: Research,
Estimates) instead.
Name: Jac, Texas.
Question: AMR Corp. (AMR: Research, Estimates).
Battipaglia: I would buy airlines here ... I think that jet fuel prices will come off their
highs, and airline stocks will do better over next six months.
Name: Am, Calif.
Question: What is your opinion on Pfizer (PFE: Research, Estimates) long- term?
Battipaglia: We're pleased that they will be able to acquire Warner Lambert (WLA:
Research, Estimates). They have a very rich pipeline and great fundamentals. We
would buy the stock here.
Name: Dr. L., Fla.
Question: Is Amgen (AMGN: Research, Estimates) a good entry around 50s? I plan
to hold for a year. How is the future outlook for the company -- any future blockbuster
drug in the pipeline?
Battipaglia: Yes, it's a good value to get in. Amgen is a diversified biotech
company, relying on new products as well as old products, to bring in sizable
earnings. We like it here.
Name: John, Ontario, Canada.
Question: What is your short-term and long-run look
for IBM (IBM: Research, Estimates)?
Battipaglia: Very positive short-term and long-term on IBM. We think they are
truly a business Internet support company with strong software and consulting
services.
Name: Jack, Germany.
Question: Do you think it is a good idea or too late to buy some big shares at the
Amazon.com (AMZN: Research, Estimates)?
Battipaglia: I'm not a fan of their model. Their size is starting to challenge their
ability to have efficiency and profitability. I would avoid it.
Name: Fethi, Istanbul, Turkey.
Question: What is your short- and long-term outlook on Nokia (NOK: Research,
Estimates)?
Battipaglia: We like them here. Think that cellular technology is proliferating. Also
their newly-struck deal for wireless Internet is very positive.
Name: Joel, Pa.
Question: What is your opinion on Xerox (XRX: Research, Estimates)? Is it a
bargain at its current price or will it go much lower?
Battipaglia: We have a negative view on Xerox. We don't see any drivers for
accelerated earnings developing any time soon.
Name: Amarjit, Calif.
Question: Shall I hold on to Microsoft (MSFT: Research, Estimates) stock or sell it?
Battipaglia: Microsoft is clearly a hold here. Windows 2000 is a successful product
for them, and the issues with DOJ will be resolved without any implications for the
company's long-term results.
Name: Kim, Canada.
Question: What About Ariba in the business-to-business space?
Battipaglia: Ariba is in the business-to-business software space. We like that
whole group. It's definitely a stock to buy.
Name: Bert, Virginia.
Question: How do you explain the drop in the stock of Johnson & Johnson (JNJ:
Research, Estimates) in the past three months? What is the near-term outlook for it
and others in the drug sector?
Battipaglia: J&J stock has been down recently over concerns about relabeling of a
major product. But we're positive on the stock looking forward and we see it going
back up to 110. Definitely a BUY at this level.
FN welcomes your e-mail questions for our "Talking Stocks" guest.
Please include your first name, state and one stock question per e-mail. Keep in
mind, "Talking Stocks" is for specific stock questions only.
If you do not see an answer to your e-mail here it is because our guest
does not cover the company.
-- compiled by Antoinette Coulton |
